<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17417" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Alveolar Gas Equation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hendrix</surname>
            <given-names>Joseph Maxwell</given-names>
          </name>
          <aff>Worldwide Clinical Trials</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Burns</surname>
            <given-names>Bracken</given-names>
          </name>
          <aff>East Tennessee State University (ETSU)</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joseph Maxwell Hendrix declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bracken Burns declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17417.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The alveolar gas equation&#x000a0;is used to calculate alveolar oxygen partial pressure, as it is impossible to collect gases directly from the alveoli. This equation provides a close estimate of <italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0;inside the alveoli. The variables in the equation can affect the <italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub> inside the alveoli in various physiological and pathophysiological states.</p>
        <p>
<bold>Alveolar Gas Equation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub> = [(<italic toggle="yes">P</italic><sub>atm</sub> &#x02212; <italic toggle="yes">P</italic><sub>H2O</sub>) <italic toggle="yes">F</italic>iO<sub>2</sub>] &#x02212; (<italic toggle="yes">P</italic><sub>a</sub>CO<sub>2</sub>/RQ)</p>
          </list-item>
        </list>
        <p>where<italic toggle="yes"> P</italic><sub>atm</sub> is the atmospheric pressure (760 mm Hg at sea level), <italic toggle="yes">P</italic><sub>H2O</sub> is the partial pressure of water (approximately 45 mm Hg), <italic toggle="yes">F</italic>iO<sub>2</sub> is the&#x000a0;fraction of inspired oxygen, <italic toggle="yes">P</italic><sub>a</sub>CO<sub>2</sub> is the partial pressure of&#x000a0;carbon dioxide&#x000a0;in alveoli (around 40-45 mmHg under normal physiological conditions), and RQ is the respiratory quotient. The value of the RQ can vary depending on the type of diet and metabolic state. RQ is different for carbohydrates, fats, and proteins; the average value is around 0.82 for the human diet. Indirect calorimetry can provide better measurements of RQ by measuring the VO<sub>2</sub> (oxygen uptake) and VCO<sub>2</sub> (carbon dioxide production).</p>
        <p>RQ = amount of CO<sub>2</sub> produced/amount of oxygen consumed</p>
        <p>At sea level, the alveolar <italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0;is:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0; = [(760 &#x02212; 47)&#x000a0;0.21] &#x02212; (40/0.8) = 99.7 mm Hg.</p>
          </list-item>
        </list>
        <p>The 3 major variables of the equation&#x000a0;are the atmospheric pressure, amount of inspired oxygen, and carbon dioxide levels. Each variable has an important clinical significance&#x000a0;and can help explain physiological and pathophysiological states.<xref ref-type="bibr" rid="article-17417.r1">[1]</xref></p>
      </sec>
      <sec id="article-17417.s2" sec-type="Function">
        <title>Function</title>
        <p>The alveolar gas equation is crucial in calculating the alveolar-arterial O<sub>2</sub> gradient (A-a gradient).</p>
        <p>
<bold>Estimation of the A-a Gradient</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal A-a gradient&#x000a0;= (Age in years + 10) / 4
<list list-type="bullet"><list-item><p>A-a gradient&#x000a0;typically increases by 5 to 7 mm Hg for every 10% increase in&#x000a0;<italic toggle="yes">F</italic>iO<sub>2</sub>.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The arterial <italic toggle="yes">P</italic>O<sub>2</sub> can be determined by obtaining an arterial blood gas.&#x000a0;Using&#x000a0;the alveolar gas equation, the partial pressure inside the alveoli can be calculated. Carbon dioxide is a crucial variable in the equation.&#x000a0;The <italic toggle="yes">P</italic>O<sub>2</sub> in alveoli can change significantly with variations in blood and alveolar carbon dioxide levels. If the rise in CO<sub>2</sub> is significant, it can displace oxygen molecules that cause hypoxemia. As atmospheric pressure reduces with increased altitude, the alveolar gas equation helps to calculate the <italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0;within the alveoli.&#x000a0;Accurately calculating&#x000a0;<italic toggle="yes">P</italic><sub>A</sub>O<sub>2&#x000a0;</sub>is&#x000a0;essential&#x000a0;for identifying hypoxemia caused by decreased atmospheric pressure and treating it with appropriate supplemental oxygen levels.<xref ref-type="bibr" rid="article-17417.r2">[2]</xref></p>
      </sec>
      <sec id="article-17417.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>The alveolar gas equation is derived from the assumption of a steady-state condition and is only valid if the underlying assumptions remain true. Low <italic toggle="yes">F</italic>iO<sub>2</sub> conditions could violate the steady state. Thus, some clinicians and scientists suggest using the detailed form of the equation. In clinical practice, the complete alveolar gas equation does not convey relevant increased accuracy, and the abbreviated equation discussed above is sufficient in calculating the <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;in alveoli.</p>
      </sec>
      <sec id="article-17417.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Atmospheric Pressure</bold>
</p>
        <p>Increasing altitude decreases the atmospheric pressure; for any given <italic toggle="yes">F</italic>iO<sub>2</sub>, there is a&#x000a0;lower <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;in the atmosphere and a lower&#x000a0;<italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0;in alveoli. For example, breathing&#x000a0;21% oxygen at sea level results in an alveolar <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;close to 100 mm Hg, whereas breathing the same percentage of oxygen at Mount Everest (at atmospheric pressure of 263 mm Hg) results in alveolar <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;close to 0 mm Hg. As we ascend, the reduction in barometric pressure can lead to hypoxemia, triggering various physiological changes.<xref ref-type="bibr" rid="article-17417.r1">[1]</xref><xref ref-type="bibr" rid="article-17417.r2">[2]</xref><xref ref-type="bibr" rid="article-17417.r3">[3]</xref>&#x000a0;Common symptoms in decreasing order of frequency include headaches, fatigue, nausea, vomiting, loss of appetite, dizziness, irritability, and disturbed sleep.</p>
        <p>The body undergoes several physiological changes that enable it to function in a low-oxygen environment. This process of gradual adjustment is known as acclimatization. This change increases the frequency and depth of breathing, cardiac output, blood pressure, and production of erythropoietin and&#x000a0;2,3-diphosphoglycerate. Without proper acclimatization or supplemental oxygen, individuals can develop high-altitude cerebral edema, acute mountain sickness, and high-altitude pulmonary edema. Conversely, increasing atmospheric pressure can significantly affect the body by increasing the amount of dissolved oxygen in the blood. A hyperbaric oxygen chamber is used as a treatment for significant carbon monoxide poisoning, decompression sickness, and non-healing ulcers.</p>
        <p>
<bold>Inspired Oxygen</bold>
</p>
        <p>Oxygen is used in the human body&#x000a0;for oxidative phosphorylation to produce adenosine triphosphate (ATP), the primary energy source for enzymatic reactions.&#x000a0;Oxygen has a high redox potential and is the last acceptor of electrons within the electron&#x000a0;transport chain. Hypoxemic patients typically present with shortness of breath and dyspnea. If hypoxia is severe, patients may develop severe lactic acidosis, cyanosis, syncope, and arrhythmias.<xref ref-type="bibr" rid="article-17417.r4">[4]</xref><xref ref-type="bibr" rid="article-17417.r5">[5]</xref></p>
        <p>The alveolar gas equation is used to calculate the alveolar and arterial <italic toggle="yes">P</italic>O<sub>2</sub> gradient (A-a)&#x000a0;difference.</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal A-a gradient&#x000a0;= (Age in years + 10) / 4</p>
          </list-item>
        </list>
        <p>Every 10% rise in the inspired fraction of oxygen increases the partial pressure of available oxygen in the alveoli by approximately 60 to 70 mm Hg.<xref ref-type="bibr" rid="article-17417.r6">[6]</xref>&#x000a0;If more than required <italic toggle="yes">F</italic>iO<sub>2</sub>&#x000a0;is given, it can lead to an increase in <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;within the alveoli, and if given for long periods, this can lead to lung injury. Higher levels of oxygen can be dangerous&#x000a0;for&#x000a0;patients with end-stage chronic obstructive pulmonary diseases, as their respiratory drive is dependent upon hypoxia (with a <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;around 60 mm Hg).</p>
        <p>Hyperoxygenation, achieved by increasing the <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;within the alveoli and plasma during intubation or procedural conscious sedation, is highly beneficial and can be easily understood using the alveolar gas equation. For example, at sea level, with no additional supplemental oxygen and under normal physiological conditions, the <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;inside the alveoli&#x000a0;is&#x000a0;approximately 100 mm Hg.</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0;= [(<italic toggle="yes">P</italic><sub>atm</sub> &#x02212;&#x000a0;<italic toggle="yes">P</italic><sub>H2O</sub>) <italic toggle="yes">F</italic>iO<sub>2</sub>] &#x02212; (<italic toggle="yes">P</italic><sub>a</sub>CO<sub>2</sub>/RQ)</p>
          </list-item>
        </list>
        <p>For 100% oxygen:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">P</italic><sub>A</sub>O<sub>2&#x000a0;</sub>= [(760 &#x02212; 47) &#x000d7; 1] &#x02212; (40 / 0.8) = 663 mm Hg</p>
          </list-item>
        </list>
        <p>However, if a patient is given 100% oxygen in the same situation, the <italic toggle="yes">P</italic>O<sub>2</sub> can be as high as 663 mm Hg. under normal physiological conditions, this provides a clinician 8 to 9 minutes to successfully intubate before a patient's partial pressure of oxygen falls below 60 mm Hg and desaturation on pulse oximetry becomes evident.</p>
        <p>Under&#x000a0;pathological conditions where diffusion is impaired, such as heart failure, pneumonia, or alveolar hemorrhage, without pre-oxygenation, the clinician may have a few seconds to a few minutes before the patient desaturates. Under these severe pathological conditions, it is recommended that an experienced clinician attempt the intubation. In these conditions, bilevel positive airway pressure can be used to pre-oxygenate and even hyperventilate the patient as long as they are hemodynamically stable, alert, awake, and able to protect the airway.</p>
        <p>
<bold>Carbon Dioxide</bold>
</p>
        <p>Carbon dioxide is the end product of carbohydrate metabolism.&#x000a0;Carbon dioxide is transported by red blood cells, mostly bound to the hemoglobin, to the lungs from peripheral tissues, where it diffuses out and allows hemoglobin to bind to oxygen (Bohr and Haldane effects). Importantly, any increase in carbon dioxide must result in a decrease in the <italic toggle="yes">P</italic>O<sub>2</sub>. For example, if a patient is breathing room air with 0.21 <italic toggle="yes">F</italic>iO<sub>2</sub>&#x000a0;and is at sea level, an increase in&#x000a0;<italic toggle="yes">P</italic><sub>a</sub>CO<sub>2</sub>&#x000a0;from 40 to 80 mm Hg decreases the <italic toggle="yes">P</italic><sub>A</sub>O<sub>2</sub>&#x000a0;from 100 to approximately 60 mm Hg, leading to hypoxemia.&#x000a0;This scenario emphasizes the importance of continuous capnography and pulse oximetry, especially during procedures where conscious sedation is used.</p>
        <p>In hypoxic conditions, the normal response is hyperventilation and increasing the minute ventilation to exhale more carbon dioxide, which decreases the partial pressure of carbon dioxide and increases <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;to some extent. For example, a 10 mm Hg decrease&#x000a0;in alveoli <italic toggle="yes">P</italic>CO<sub>2&#x000a0;</sub>can increase the <italic toggle="yes">P</italic>O<sub>2</sub>&#x000a0;by approximately 10 to 12 mm Hg, which can be significant in acute and chronic disease processes essential for survival.<xref ref-type="bibr" rid="article-17417.r7">[7]</xref></p>
      </sec>
      <sec id="article-17417.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>The alveolar gas equation has limitations, especially in low atmospheric pressures and low-inspired <italic toggle="yes">F</italic>iO<sub>2</sub>. With acclimatization, severe acidosis, and carbon monoxide poisoning, the body's physiology and pathophysiology change substantially,&#x000a0;and the equation cannot be used reliably.</p>
      </sec>
      <sec id="article-17417.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The alveolar gas equation&#x000a0;is used to calculate alveolar oxygen partial pressure, as it is impossible to collect gases directly from the alveoli. The equation helps calculate and closely estimate the <italic toggle="yes">P</italic><sub>a</sub>O<sub>2</sub>&#x000a0;inside the alveoli.</p>
        <p>Enhancing healthcare team outcomes in the context of understanding and applying the alveolar gas equation requires a multifaceted approach involving various healthcare professionals.</p>
        <p>
<bold>Clinicians</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skills and responsibilities:
<list list-type="bullet"><list-item><p>Thorough understanding of respiratory physiology and the alveolar gas equation.</p></list-item><list-item><p>Ability to interpret arterial blood gas results in conjunction with the alveolar gas equation.</p></list-item><list-item><p>Diagnosis and treatment of respiratory conditions.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Strategy and ethics:
<list list-type="bullet"><list-item><p>Ensure accurate diagnosis and appropriate treatment plans based on alveolar gas equation calculations.</p></list-item><list-item><p>Communicate findings and treatment plans clearly to other team members and patients.</p></list-item><list-item><p>Consider the ethical implications of treatment decisions, especially in critical care situations.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Advanced Practice Providers</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skills and responsibilities:
<list list-type="bullet"><list-item><p>Proficiency in performing and interpreting arterial blood gas tests.</p></list-item><list-item><p>Ability to apply the alveolar gas equation in clinical practice.</p></list-item><list-item><p>Monitoring patient response to respiratory interventions.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Strategy and ethics:
<list list-type="bullet"><list-item><p>Collaborate closely with clinicians to ensure consistent application of the alveolar gas equation in patient care.</p></list-item><list-item><p>Educate patients and families about respiratory health and treatments.</p></list-item><list-item><p>Advocate for patient safety and comfort during respiratory interventions.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Nurses</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skills and responsibilities:
<list list-type="bullet"><list-item><p>Understanding the basics of the alveolar gas equation and its clinical relevance.</p></list-item><list-item><p>Proficiency in collecting arterial blood gas samples and monitoring oxygen therapy.</p></list-item><list-item><p>Recognizing signs of respiratory distress.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Strategy and ethics:
<list list-type="bullet"><list-item><p>Implement clinician-ordered treatments based on alveolar gas equation calculations.</p></list-item><list-item><p>Monitor patients closely for changes in their respiratory status.</p></list-item><list-item><p>Ensure patient comfort and dignity during respiratory care.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Respiratory Therapists</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skills and responsibilities:
<list list-type="bullet"><list-item><p>Expert knowledge of the alveolar gas equation and its practical applications.</p></list-item><list-item><p>Proficiency in administering various forms of respiratory therapy.</p></list-item><list-item><p>Ability to adjust ventilator settings based on alveolar gas equation calculations.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Strategy and ethics:
<list list-type="bullet"><list-item><p>Collaborate with clinicians to optimize respiratory care plans.</p></list-item><list-item><p>Educate other team members on the nuances of respiratory physiology and therapy.</p></list-item><list-item><p>Ensure proper use and maintenance of respiratory equipment.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Pharmacists</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skills and responsibilities:
<list list-type="bullet"><list-item><p>Knowledge of medications that can affect respiratory function and gas exchange.</p></list-item><list-item><p>Understanding how drug therapies can impact alveolar gas equation variables.</p></list-item><list-item><p>Ability to recommend appropriate medications for respiratory conditions.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Strategy and ethics:
<list list-type="bullet"><list-item><p>Collaborate with the healthcare team to optimize medication regimens for respiratory patients.</p></list-item><list-item><p>Provide guidance on potential drug interactions that may affect respiratory function.</p></list-item><list-item><p>Ensure safe and effective use of respiratory medications.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Clinical Laboratory Scientists</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skills and responsibilities:
<list list-type="bullet"><list-item><p>Expertise in arterial blood gas analysis techniques.</p></list-item><list-item><p>Ability to troubleshoot and maintain blood gas analyzers.</p></list-item><list-item><p>Understanding of pre-analytical factors affecting arterial blood gas results.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Strategy and ethics:
<list list-type="bullet"><list-item><p>Ensure that arterial blood gas results are obtained and reported promptly and accurately to enable the correct application of the alveolar gas equation.</p></list-item><list-item><p>Collaborate with other team members to interpret complex or unusual results.</p></list-item><list-item><p>Maintain quality control standards for arterial blood gas testing.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Interprofessional Communication and Care Coordination</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Regular team meetings to discuss complex respiratory cases and share insights from different perspectives.</p>
          </list-item>
          <list-item>
            <p>Implementation of standardized communication protocols for reporting critical arterial blood gas results and alveolar gas equation calculations.</p>
          </list-item>
          <list-item>
            <p>Development of interdisciplinary care plans incorporating the alveolar gas equation.</p>
          </list-item>
          <list-item>
            <p>Use of electronic health records to document and share alveolar gas equation calculations and related interventions.</p>
          </list-item>
          <list-item>
            <p>Collaborative research projects to improve the application of the alveolar gas equation in clinical practice.</p>
          </list-item>
        </list>
        <p>
<bold>Enhancing Patient-Centered Care</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Educating patients and families about the importance of the alveolar gas equation in managing their respiratory health.</p>
          </list-item>
          <list-item>
            <p>Involving patients in decision-making processes related to respiratory treatments.</p>
          </list-item>
          <list-item>
            <p>Tailoring oxygen therapy and other interventions based on individual patient needs and preferences.</p>
          </list-item>
          <list-item>
            <p>Providing culturally competent care that considers diverse patient backgrounds and beliefs.</p>
          </list-item>
        </list>
        <p>
<bold>Improving Patient Safety and Team Performance</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Implementing double-check systems for critical alveolar gas equation calculations.</p>
          </list-item>
          <list-item>
            <p>Conducting regular training sessions on the use and interpretation of the alveolar gas equation.</p>
          </list-item>
          <list-item>
            <p>Developing and adhering to evidence-based protocols for respiratory care based on alveolar gas equation principles.</p>
          </list-item>
          <list-item>
            <p>Encouraging a culture of open communication where team members can voice concerns or suggestions related to respiratory care.</p>
          </list-item>
          <list-item>
            <p>Conducting regular audits and quality improvement initiatives to enhance the team's proficiency in applying the alveolar gas equation.</p>
          </list-item>
        </list>
        <p>By leveraging the diverse skills and perspectives of the healthcare team, implementing effective communication strategies, and focusing on patient-centered care, the application of the alveolar gas equation can significantly enhance patient outcomes, safety, and overall team performance in respiratory care.</p>
      </sec>
      <sec id="article-17417.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17417&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17417">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17417/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17417">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17417.s8">
        <title>References</title>
        <ref id="article-17417.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diehl</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Mercat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pesenti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Understanding hypoxemia on ECCO<sub>2</sub>R: back to the alveolar gas equation.</article-title>
            <source>Intensive Care Med</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>255</fpage>
            <page-range>255-256</page-range>
            <pub-id pub-id-type="pmid">30324288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17417.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bashar</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Vahedian-Azimi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farzanegan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goharani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shojaei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hatamian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mosavinasab</surname>
                <given-names>SMM</given-names>
              </name>
              <name>
                <surname>Khoshfetrat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khatir</surname>
                <given-names>MAK</given-names>
              </name>
              <name>
                <surname>Tomdio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AC</given-names>
              </name>
              <collab>MORZAK Collaborative</collab>
            </person-group>
            <article-title>Comparison of non-invasive to invasive oxygenation ratios for diagnosing acute respiratory distress syndrome following coronary artery bypass graft surgery: a prospective derivation-validation cohort study.</article-title>
            <source>J Cardiothorac Surg</source>
            <year>2018</year>
            <month>Nov</month>
            <day>27</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <pub-id pub-id-type="pmid">30482210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17417.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Iterson</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Use of 'ideal' alveolar air equations and corrected end-tidal PCO<sub>2</sub> to estimate arterial PCO<sub>2</sub> and physiological dead space during exercise in patients with heart failure.</article-title>
            <source>Int J Cardiol</source>
            <year>2018</year>
            <month>Jan</month>
            <day>01</day>
            <volume>250</volume>
            <fpage>176</fpage>
            <page-range>176-182</page-range>
            <pub-id pub-id-type="pmid">29054325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17417.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zavorsky</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Hsia</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Borland</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Gu&#x000e9;nard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van der Lee</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Steenbruggen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Naeije</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dinh-Xuan</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Standardisation and application of the single-breath determination of nitric oxide uptake in the lung.</article-title>
            <source>Eur Respir J</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28179436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17417.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conkin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Equivalent Air Altitude and the Alveolar Gas Equation.</article-title>
            <source>Aerosp Med Hum Perform</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>87</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-4</page-range>
            <pub-id pub-id-type="pmid">26735235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17417.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roy</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Secomb</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>Theoretical analysis of the determinants of lung oxygen diffusing capacity.</article-title>
            <source>J Theor Biol</source>
            <year>2014</year>
            <month>Jun</month>
            <day>21</day>
            <volume>351</volume>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">24560722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17417.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nose</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Conditions under which alveolar air equations are modified and the compensation terms of saturated water vapor in those equations].</article-title>
            <source>Masui</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-35</page-range>
            <pub-id pub-id-type="pmid">15852634</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
